Skip to main content

and
  1. Article

    Open Access

    Co-localization of clusters of TCR-regulated genes with TAD rearrangements

    Gene expression has long been known to be influenced by the relative proximity of DNA regulatory elements. Topologically associating domains (TADs) are self-interacting genomic regions involved in regulating g...

    Galen F. Gao, Peng Li, Warren J. Leonard in BMC Genomics (2023)

  2. No Access

    Article

    Cancer aneuploidies are shaped primarily by effects on tumour fitness

    Aneuploidies—whole-chromosome or whole-arm imbalances—are the most prevalent alteration in cancer genomes1,2. However, it is still debated whether their prevalence is due to selection or ease of generation as pas...

    Juliann Shih, Shahab Sarmashghi, Nadja Zhakula-Kostadinova, Shu Zhang in Nature (2023)

  3. Article

    Open Access

    Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE

    Natural killer (NK) cells represent a critical component of the innate immune system’s response against cancer and viral infections, among other diseases. To distinguish healthy host cells from infected or tum...

    Galen F. Gao, Dajiang Liu, **aowei Zhan, Bo Li in BMC Biology (2022)

  4. Article

    Open Access

    Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells

    Hugh S. Gannon, Tao Zou, Michael K. Kiessling, Galen F. Gao in Nature Communications (2022)

  5. Article

    Open Access

    Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities

    Alterations in non-driver genes represent an emerging class of potential therapeutic targets in cancer. Hundreds to thousands of non-driver genes undergo loss of heterozygosity (LOH) events per tumor, generati...

    Caitlin A. Nichols, William J. Gibson, Meredith S. Brown in Nature Communications (2020)

  6. Article

    Open Access

    Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells

    Systematic exploration of cancer cell vulnerabilities can inform the development of novel cancer therapeutics. Here, through analysis of genome-scale loss-of-function datasets, we identify adenosine deaminase ...

    Hugh S. Gannon, Tao Zou, Michael K. Kiessling, Galen F. Gao in Nature Communications (2018)